drug
FAVLYXA
updated 5mo agoby Avyxa Pharma LLC
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval134 co-mentions · 66 sources
- drugEfudex73 co-mentions · 72 sources
- drugFLUOROURACIL73 co-mentions · 72 sources
- companyFresenius Kabi USA LLC12 co-mentions · 12 sources
- drugRNS-6012 co-mentions · 12 sources
- tagOncology5 co-mentions · 2 sources
- drugOXALIPLATIN1 co-mentions · 1 sources
- drugEntia1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying FAVLYXA
- phase2Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- phase2AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- phase1A Study of ASP3082 in Adults With Advanced Solid Tumors
- phase3Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- phase2A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC
- phase3A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- phase2Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- phase2A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
News(1)
- Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic CancerDeirdre J. Cohen, MD, MS, discusses clinical decision-making and the comparative efficacy of FOLFIRINOX and NALIRIFOX in metastatic pancreatic cancer.onclive · 5mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that